Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIARA: Clofarabine, Cytarabine, and Idarubicin in High-Risk AML
NCT01534702Phase 2Unknown
- Sponsor
- Hannover Medical School
- Start
- Jan 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Hannover Medical School. Status: unknown.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01534702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534702.